Tadatomo Kawai

Title: Tadatomo Kawai: Innovator in Injectable Compositions

Introduction

Tadatomo Kawai is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of biomedical engineering, particularly in the development of injectable compositions for medical applications. His innovative work focuses on enhancing the effectiveness and safety of injectable materials used in various medical procedures.

Latest Patents

Tadatomo Kawai holds a patent for an "Intracorporeally injectable composition for implanting highly." This invention provides a non-toxic composition of atelocollagen that exhibits an excellent, long-lasting skin swelling effect. The composition is characterized by its low viscosity, good fluidity, easy injectability, and low antigenicity, which prevents calcification. The preparation involves treating an aqueous suspension of atelocollagen with a buffer suitable for physiological conditions. The suspension can contain atelocollagen in a concentration of 55 to 75 mg/ml, with approximately 20 to 100% by weight of atelocollagen being cross-linked with a polyepoxy compound.

Career Highlights

Tadatomo Kawai is associated with Koken Company, Limited, where he continues to innovate and develop new medical technologies. His work has been instrumental in advancing the field of injectable biomaterials, contributing to improved patient outcomes in medical treatments.

Collaborations

Tadatomo Kawai has collaborated with Teruo Miyata, a fellow innovator, to further enhance the research and development of injectable compositions. Their partnership has led to significant advancements in the field.

Conclusion

Tadatomo Kawai's contributions to the field of injectable compositions highlight his role as a leading inventor in biomedical engineering. His innovative patent demonstrates a commitment to improving medical technologies for better patient care.